[144] Pacific Biosciences of California, Inc. SEC Filing

Rhea-AI Filing Summary

Pacific Biosciences (PACB) filed a Form 144 reporting a proposed sale of 26,836 restricted common shares acquired on 08/15/2025. The filing lists the broker as Morgan Stanley Smith Barney LLC and shows an aggregate market value of $35,173.95 with an approximate sale date of 08/18/2025 on NASDAQ. The issuer's total shares outstanding are reported as 300,370,611. The filer indicates there were no securities sold in the past three months for the same account and signs the standard representation that they are not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Small proposed sale of restricted shares via Morgan Stanley; listed value is $35k with no recent sales reported.

The Form 144 documents a proposed disposition of 26,836 restricted common shares acquired on 08/15/2025 and slated for sale on 08/18/2025 through Morgan Stanley Smith Barney LLC. The filing provides the aggregate market value of $35,173.95 and notes 300,370,611 shares outstanding. The filer reports no related sales in the prior three months and affirms no knowledge of undisclosed material adverse information. Given the absolute size and the information disclosed, this appears to be a routine notification rather than a material corporate development.

Corporate Governance Expert

TL;DR Routine insider reporting required by Rule 144; includes standard representations and broker information.

The notice identifies the securities as restricted stock acquired from the issuer on 08/15/2025 and lists the broker and expected sale date. The filing includes the customary certification that the seller does not possess undisclosed material information. No additional disclosures, trading plan dates, or related-party sale aggregation details are provided. This Form 144 fulfils regulatory notice requirements without presenting new governance or control issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26836	35173.95	300370611	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock	Issuer			26836	08/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PACB's Form 144 report?

PACB's Form 144 reports a proposed sale of 26,836 restricted common shares with an aggregate market value of $35,173.95.

When were the shares acquired and when is the proposed sale date for PACB?

The shares were acquired on 08/15/2025, and the approximate date of sale is listed as 08/18/2025.

Which broker is handling the proposed sale for PACB shares?

The broker named is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY.

Did the filer report any sales of PACB securities in the past three months?

No; the filing states "Nothing to Report" for securities sold during the past three months.

How many PACB shares are outstanding according to the filing?

The filing reports 300,370,611 shares outstanding.